Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Allergologie Select|September 17, 2021
A new era has begun: Treatment of atopic dermatitis with biologicsDora Stölzl, Stephan Weidinger, Katharina DrerupExperimental Dermatology|September 5, 2020
Stratum corneum lipidomics analysis reveals altered ceramide profile in atopic dermatitis patients across body sites with correlated changes in skin microbiomeHila Emmert, Hansjörg Baurecht, Frederieke Thielking, et al.The Journal of Investigative Dermatology|December 29, 2024
Tralokinumab Treatment of Atopic Dermatitis Induces a Progressive Transcriptomic ResponseRashmi Tandon, Inken Harder, Dora Stölzl, et al.Allergologie Select|March 14, 2025
The importance of registries in clinical practice: Insights from the national atopic dermatitis registry TREATgermanyTatjana Honstein, Barbara Kind, Dora Stölzl, et al.Allergy|April 20, 2024
Inhibition of RNase 7 by RNase inhibitor promotes inflammation and Staphylococcus aureus growth: Implications for atopic dermatitisFranziska Rademacher, Annika Scheel, Regine Gläser, et al.The Journal of Allergy and Clinical Immunology|July 3, 2020
Atopic dermatitis displays stable and dynamic skin transcriptome signaturesLena Möbus, Elke Rodriguez, Inken Harder, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
Stratum corneum and microbial biomarkers precede and characterize childhood atopic dermatitisMelina Fonfara, Jan Hartmann, Dora Stölzl, et al.The Journal of Investigative Dermatology|September 15, 2022
Quantitative Proteomics Identifies Reduced NRF2 Activity and Mitochondrial Dysfunction in Atopic DermatitisMichael Koch, Tobias Kockmann, Elke Rodriguez, et al.Acta Dermato-Venereologica|May 29, 2023
Effects of Early Emollient Use in Children at High Risk of Atopic Dermatitis: A German Pilot StudyInken Harder, Dora Stölzl, Nicole Sander, et al.The British Journal of Dermatology|March 26, 2024
Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitisNicole Sander, Dora Stölzl, Melina Fonfara, et al.Pageof 3